- TheStreet.com•16 hours ago
Teva Pharmaceuticals (TEVA) stock is rising in early morning trading today after the company won antitrust approval to purchase Allergan's (AGN) generics business.
- Market Realist•17 hours ago
US corporates dominated the primary market for high-grade bonds in the week ending July 22—making up 52.8% or $16.0 billion of all the issues.
Teva Pharmaceutical Industries LimitedNYSE
After hours: 54.790.00 (0.00%) as of 4:39 PM EDT
|Bid||54.71 x 100|
|Ask||54.88 x 100|
|52wk Range||48.01 - 71.68|
|Day's Range||54.58 - 55.48|
|Avg Vol (3m)||6,217,103|
As of 4:02 PM EDT. Market closed.